For example, Zhou et al have shown a significantly increased lung cancer risk in subjects carrying at least 5 variant alleles of XPD Asp312Asn, Lys751Gln and XRCC1 Arg399Gln polymorphisms compared to subjects with no variant allele [54]. This evidence concerns the gene XRCC1 and lung carcinoma.